Velorum Therapeutics
YC W24 · Active · Breakthrough medicines unlocking the biology of heme
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCW24 | |
| Other | Active | YCW21 | |
| Other | Active | YCW24 | |
| Other | Active | YCW24 | |
| Other | Active | YCS21 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Acquired | YCW22 | |
| Other | Active | YCW24 | |
| AI | Active | YCS22 | |
| Other | Inactive | YCS18 | |
| AI | Active | YCW15 |
Also from W24
All of W24About Velorum Therapeutics
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
- YC batch
- W24 · Winter 2024
- Status, per YC
- Active
- Category
- Other
- Team size
- 5
- Location
- San Francisco, CA, USA
- Checked
- 35m ago
YC tags: Biotech, Healthcare, Therapeutics, Drug discovery, Oncology
Velorum Therapeutics: questions
Which YC batch was Velorum Therapeutics in?
Velorum Therapeutics was in Y Combinator's Winter 2024 batch (W24).
Is Velorum Therapeutics still active?
Y Combinator lists Velorum Therapeutics as active.
Where is Velorum Therapeutics based?
Velorum Therapeutics lists San Francisco, CA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.